Approval · Notice of Compliance 22544 · 2019
TRAZIMERA: Notice of Compliance 22544
Issued August 15, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22544
- Date
- August 15, 2019
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Labelling updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRAZIMERA | Not yet assigned | — |
Medicinal ingredients
- TRASTUZUMAB 150 MG per VIAL
- TRASTUZUMAB 440 MG per VIAL